Affectis Pharmaceuticals
About:
Affectis Pharmaceuticals is a pharmaceuticals company developing novel drugs.
Website: http://www.affectis.com
Top Investors: KfW, Bayern Kapital, EQT Life Sciences, LSP BioVentures, EMBL Ventures
Description:
Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
Total Funding Amount:
19.4M EUR
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Dortmund, Nordrhein-Westfalen, Germany
Founded Date:
2002-01-01
Contact Email:
info(AT)affectis.de
Founders:
Number of Employees:
11-50
Last Funding Date:
2010-03-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai